|
Variable
|
Boys (N = 60)
|
Girls (N = 60)
|
p value
|
Total (N = 120)
|
|---|
|
Age (years)
|
11.9 (2.9)
|
12.5 (3.5)
|
0.363*
|
12.2 (3.2)
|
|
Age at 1st diagnosis (years)
|
5.1 (3.8)
|
4.6 (3.5)
|
0.435*
|
4.9 (3.7)
|
|
Duration of ART treatment (years)
|
6.6 (3.4)
|
7.6 (4.2)
|
0.98*
|
7.0 (3.9)
|
|
Overall Age group: n (%)
|
|
School age
|
11 (18.8)
|
11 (18.3)
| |
22 (18.3)
|
|
Early adolescence
|
25 (41.7)
|
33 (55.0)
| |
58 (48.3)
|
|
Mid adolescence
|
15 (25.0)
|
11 (18.3)
| |
26 (21.7)
|
|
Late adolescence
|
9 (15.0)
|
5 (8.3)
|
0.472**
|
14 (11.7)
|
|
School Attendance: n (%)
|
60 (100)
|
58 (96.7)
|
0.476**
|
118 (98.3)
|
|
On Antiretrovirals: n (%)
|
59 (98.3)
|
58 (96.7)
|
0.559**
|
117 (97.5)
|
|
Prevalence of disclosure: n (%)
|
18 (30.0)
|
25 (41.7)
|
0.253**
|
43 (35.8)
|
|
∫Disclosure rate by age-group: n (%)
|
|
School age
|
1 (9.1)
|
2 (18.2)
| |
3 (13.6)
|
|
Early adolescence
|
3 (12.0)
|
10 (30.3)
| |
13 (22.4)
|
|
Mid adolescence
|
6 (40.0)
|
8 (72.7)
| |
14 (53.8)
|
|
Late adolescence
|
8 (88.9)
|
5 (100)
|
0.001**
|
13 (92.9)
|
|
Who made disclosure: N = 43 n (%)
|
|
Mother alone
|
7 (38.9)
|
8 (32.0)
| |
15 (34.9)
|
|
Father alone
|
0 (0.0)
|
5 (20.0)
| |
5 (11.6)
|
|
Health worker
|
4 (22.2)
|
9 (36.0)
| |
13 (30.2)
|
|
Grandmother
|
2 (11.1)
|
1 (4.0)
| |
3 (7.0)
|
|
¶Others
|
5 (27.8)
|
2 (8.0)
|
0.212**
|
7 (16.3)
|
- Values presented as mean (SD), unless otherwise indicated, n (%) = Frequency (percentage), *Independent t-test p-values reported, **Chi-square p-values reported
- ∫Disclosure rate by age-group calculated based on overall number of children within each age group category (disclosed and non-disclosed)
- ¶Others: mother and father combined, Sister, Brother, Neighbour, Step-mother, Guardian, and unknown person
- School age (6–9 years), Early adolescence (10–13 years), Middle adolescence (14–16 years), Late adolescence (17–18 years) as described by Cromber et al. [17]
